Osmol Therapeutics
New Haven
About Osmol Therapeutics
Osmol Therapeutics develops treatment to prevent chemotherapy-induced peripheral neuropathy. The company was founded in 2016 and is headquartered in New Haven, Connecticut, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2022)
- Website: osmoltherapeutics.com
- Phone: 617-719-9406
Industries & Categories
Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/osmol-therapeutics-57793 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.